Adrenocortical carcinoma and a sporadic MEN1 mutation in a 3-year-old girl: a case report
暂无分享,去创建一个
Jae Wook Lee | W. Cho | Byung-Kyu Suh | M. Jung | Nayeong Lee | M. Ahn | Sung Eun Kim | J. Chung | J. Yim | Myungshin Kim
[1] J. Jung,et al. Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma , 2020, Journal of clinical research in pediatric endocrinology.
[2] M. Fragoso,et al. Pediatric adrenocortical tumor - review and management update. , 2020, Current opinion in endocrinology, diabetes, and obesity.
[3] C. Stratakis,et al. Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis , 2019, Front. Endocrinol..
[4] P. Novotny,et al. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017 , 2018, Hormone Research in Paediatrics.
[5] Kyungwon Oh,et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects , 2018, Korean journal of pediatrics.
[6] Hae-sang Lee,et al. Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma , 2016, Journal of Korean medical science.
[7] Dae-Yeol Lee,et al. Virilizing Adrenocortical Carcinoma Advancing to Central Precocious Puberty after Surgery , 2015, Korean journal of family medicine.
[8] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[9] A. Tabarin,et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines. , 2015, The Journal of clinical endocrinology and metabolism.
[10] E. Lalli,et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Gow,et al. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. , 2013, Journal of pediatric surgery.
[12] S. Gruber,et al. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.
[13] S. Kropf,et al. Systemic Treatment of Adrenocortical Carcinoma in Children: Data from the German GPOH-MET 97 Trial , 2012, Klinische Pädiatrie.
[14] J. Bilezikian,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.
[15] M. Platten,et al. Oncocytic adrenocortical neoplasms--a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. , 2011, Human pathology.
[16] H. Koh,et al. Virilizing Adrenocortical Oncocytoma in a Child: A Case Report , 2010, Journal of Korean medical science.
[17] R. Ribeiro,et al. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[18] J. Hwang,et al. Virilizing adrenocortical carcinoma in a child with Turner syndrome and somatic TP53 gene mutation , 2010, European Journal of Pediatrics.
[19] J. Hah. Intensive chemotherapy with autologous PBSCT for advanced adrenocortical carcinoma in a child. , 2008, Journal of pediatric hematology/oncology.
[20] C. Teinturier,et al. Clinical and prognostic aspects of adrenocortical neoplasms in childhood. , 1999, Medical and pediatric oncology.